Mutated T7 RNA Polymerases
US9540670B2 · kind B2 · utility
0Cited by
2References
12Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 8, 2012 |
| Grant date | Jan 10, 2017 |
| Priority date | — |
| Expiry date | Apr 25, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y207/07006
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention pertains to a mutated T7 RNA polymerase and its use, the T7 RNA polymerase being mutated at position 744, the glutamine (Q) being replaced by an amino acid selected from arginine (Q744R), leucine (Q744L) or proline (Q744P).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.